Research ArticleNEUROPHARMACOLOGY
Methylenedioxymethamphetamine Decreases Plasmalemmal and Vesicular Dopamine Transport: Mechanisms and Implications for Neurotoxicity
J. Paul Hansen, Evan L. Riddle, Verónica Sandoval, Jeffrey M. Brown, James W. Gibb, Glen R. Hanson and Annette E. Fleckenstein
Journal of Pharmacology and Experimental Therapeutics March 2002, 300 (3) 1093-1100; DOI: https://doi.org/10.1124/jpet.300.3.1093
J. Paul Hansen
Evan L. Riddle
Verónica Sandoval
Jeffrey M. Brown
James W. Gibb
Glen R. Hanson
Annette E. Fleckenstein
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 300, Issue 3
1 Mar 2002
Research ArticleNEUROPHARMACOLOGY
Methylenedioxymethamphetamine Decreases Plasmalemmal and Vesicular Dopamine Transport: Mechanisms and Implications for Neurotoxicity
J. Paul Hansen, Evan L. Riddle, Verónica Sandoval, Jeffrey M. Brown, James W. Gibb, Glen R. Hanson and Annette E. Fleckenstein
Journal of Pharmacology and Experimental Therapeutics March 1, 2002, 300 (3) 1093-1100; DOI: https://doi.org/10.1124/jpet.300.3.1093
Research ArticleNEUROPHARMACOLOGY
Methylenedioxymethamphetamine Decreases Plasmalemmal and Vesicular Dopamine Transport: Mechanisms and Implications for Neurotoxicity
J. Paul Hansen, Evan L. Riddle, Verónica Sandoval, Jeffrey M. Brown, James W. Gibb, Glen R. Hanson and Annette E. Fleckenstein
Journal of Pharmacology and Experimental Therapeutics March 1, 2002, 300 (3) 1093-1100; DOI: https://doi.org/10.1124/jpet.300.3.1093
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement